11
Participants
Start Date
October 31, 2009
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
HGS1029
HGS1029 will be given as a 15-minute IV infusion (in the vein) once weekly for 3 consecutive weeks, followed by 1 week off.
Mayo Clinic, Rochester
Hackensack University Medical Center, Hackensack
Oxford Cancer and Haematology Centre, Headington
The Institute of Cancer Research, Belmont, Sutton, Surrey
Cancer Research UK Centre, Southampton
Lead Sponsor
Human Genome Sciences Inc.
INDUSTRY